ロード中...
Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats
SIMPLE SUMMARY: The use of cannabidiol (CBD)-rich hemp-based nutraceuticals is increasing in dogs and cats for disorders related to anxiety, seizures, cancer and pain. To date, there is little information related to appropriate dosing or long-term effects on serum chemistry or complete blood counts...
保存先:
| 出版年: | Animals (Basel) |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6826847/ https://ncbi.nlm.nih.gov/pubmed/31635105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ani9100832 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|